European Orphan Diseases Market


December 31, 2008
88 Pages - SKU: MC2204428
License type:
Liver Diseases – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Liver Diseases – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Liver Diseases - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Liver Diseases,  |  read more...
$2,000.00
Ocular Inflammation – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Ocular Inflammation – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Ocular Inflammation - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Ocular Inflammation,  |  read more...
$2,000.00
Leg Ulcers – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Leg Ulcers – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Leg Ulcers - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Leg Ulcers,  |  read more...
$2,000.00
House Dust Mite Allergy – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
House Dust Mite Allergy – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'House Dust Mite Allergy - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic  |  read more...
$2,000.00
Oropharyngeal Cancer – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Oropharyngeal Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Oropharyngeal Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Oropharyngeal Cancer,  |  read more...
$2,000.00
Pulmonary Tuberculosis – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Pulmonary Tuberculosis – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Pulmonary Tuberculosis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Pulmonary Tuberculosis,  |  read more...
$2,000.00
Streptococcus Pneumoniae Infection – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Streptococcus Pneumoniae Infection – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Streptococcus Pneumoniae Infection - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for  |  read more...
$2,000.00
Muscle Atrophy – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Muscle Atrophy – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Muscle Atrophy - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Muscle Atrophy,  |  read more...
$2,000.00
Metastatic Ovarian Cancer – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Metastatic Ovarian Cancer – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Metastatic Ovarian Cancer - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for  |  read more...
$2,000.00
Influenza B Infections – Pipeline Review, H1 2013
4/30/2013 | published by: Global Markets Direct
Influenza B Infections – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Influenza B Infections - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for  |  read more...
$2,000.00